Quantification of tumor immune infiltration revealed decreased macrophages, neutrophilic and monocytic myeloid cells, increased CD8 and CD4 T-lymphocytes, and no change in Tregs or NK cells following treatment (Figure 5B&D). The gene discussed is CD4; the disease is neoplasm.